| 09/04/2026 | WuXi XDC Cayman Inc. | 1201(L) | -6,216,540(L) | | 468,853,184(L) | 60.67 | | 09/04/2026 | WuXi Biologics (Cayman) Inc. | 1201(L) | -6,216,540(L) | | 468,853,184(L) | 60.67 | | 31/03/2026 | Advantech Capital Investment V Limited | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Vivo Capital Fund VIII, L.P. | 1201(L) | -90,718,100(L) | | 0(L) | 0.00 | | 31/03/2026 | Success Growth Limited | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Advantech Capital II Master Investment Limited | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Golden Sage Investments Limited | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Advantech Capital Partners II Limited | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Advantech Capital II L.P. | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 31/03/2026 | Vivo Capital LLC | 1205(L) | -103,245,000(L) | | 0(L) | 0.00 | | 31/03/2026 | WuXi Biologics (Cayman) Inc. | 1101(L) | +11,370,590(L) | | 475,069,724(L) | 61.47 | | 31/03/2026 | WuXi XDC Cayman Inc. | 1101(L) | +11,370,590(L) | | 475,069,724(L) | 61.47 | | 31/03/2026 | Vivo Capital VIII, LLC | 1205(L) | -103,245,000(L) | | 0(L) | 0.00 | | 31/03/2026 | 彭其前 | 1704(L) | -32,990,466(L) | | 16,146,334(L) | 2.09 | | 24/03/2026 | Chengwei Evergreen Capital, LP | 1704(L) | -54,230,800(L) | | 0(L) | 0.00 | | 24/03/2026 | Chengwei Evergreen Management, LLC | 1704(L) | -54,230,800(L) | | 0(L) | 0.00 | | 17/03/2026 | WuXi Biologics (Cayman) Inc. | 1001(L) | +463,672,734(L) | | 463,672,734(L) | 60.00 | | 17/03/2026 | WuXi XDC Cayman Inc. | 1001(L) | +463,672,734(L) | | 463,672,734(L) | 60.00 | | | 1 |
|